期刊文献+

加兰肽及其受体在人嗜铬细胞瘤中的表达及意义 被引量:1

Expression of Galanin and Galanin Receptors in Human Pheochromocytoma and its Significance
原文传递
导出
摘要 [目的]探讨加兰肽(GAL)及其受体(GALR1、GALR2)在嗜铬细胞瘤中的表达及意义。[方法]分析功能不同嗜铬细胞瘤患者临床特点,ELISA法检测功能组(n=130)、功能隐匿组(n=26)、高血压组(n=30)和健康组(n=30)的血清GAL水平;免疫组化法检测GAL、GALR1和GALR2的表达水平。[结果]功能隐匿组与功能组患者年龄、性别、肿瘤性质、部位、肿瘤数目及多巴胺、尿皮醇水平均无显著性差异,两组24h肾上腺素、去甲肾上腺素水平有显著性差异(P<0.001)。功能组、功能隐匿组、高血压组和健康组的血清GAL浓度无显著性差异。功能组、功能隐匿组GAL阳性表达率分别为94.6%和23.1%(P<0.001),两组GALR1阳性表达率分别为95.4%和96.2%(P>0.05),两组GALR2阳性表达率分别为86.9%和34.6%(P<0.001)。[结论]嗜铬细胞瘤中分泌儿茶酚胺功能与患者血清GAL浓度无关,可能与肿瘤组织中GAL及GALR2的表达有关。 [Purpose] To investigate the expression of galanin(GAL) and galanin receptors(GALR1,GALR2) in human pheochromocytoma.[Methods] The clinical features of pheochromocytoma with different function were analyzed.The serum GAL levels of function group(n=130),function hidden group(n=26),high BP group(n=30) and heathy group(n=30) were detected by ELISA.Expression of GAL,GALR1 and GALR2 was detected by immunohistochemical method.[Results] There was no significant difference in age,gender,the nature of tumor,location,number of tumors,dopamine and urinary free cortisol(UFC) levels between function hidden group and function group,but 24h epinephrine,norepinephrine levels were significantly different between the 2 groups.The serum GAL levels among function group,function hidden group,high BP group and heathy group was not significantly different.The positive rate of GAL in function group and function hidden group was 94.6% and 23.1%,respectively(P0.001).The positive rate of GALR1 in the 2 groups was 95.4% and 96.2%(P0.05),and the positive rate of GALR2 in the 2 groups was 86.9% and 34.6%,respectively(P0.001).[Conclusions] The function of secrete the catecholamine in pheochromocytoma does not correlate with the level of serum GAL,it is possible correlate with the expression of GAL and GALR2 in the tumor.
出处 《肿瘤学杂志》 CAS 2011年第2期122-125,共4页 Journal of Chinese Oncology
关键词 加兰肽 促生长激素神经肽受体 嗜铬细胞瘤 儿茶酚胺 galanin GALR pheochromocytoma catecholamine
  • 相关文献

参考文献10

  • 1黄循.嗜铬细胞瘤[A].吴阶平.泌尿外科学[C].济南:山东科学技术出版社,2004.1683.
  • 2Tatemoto K, ROkaeus A, Jornwall H, et al. Galanina-a novel biologically active pepticle from porcine intestine[J]. FEBS Lett, 1983, 164(1):124-128.
  • 3Fathi Z, Battaglino PM, Iben LG, et al. Molecular characterization, pharmacological properties and chromosomal localization of the human GALR2 galanin receptor [J]. Brain Res Mol Brain Res, 1998, 58 (1-2): 156-169.
  • 4Habert-Ortoli E, Amiranoff B, Loquet I, et al. Molecular cloning of a functional human galanin receptor [J]. Proc Natl Acad Sci USA, 1994, 91 (21):9780-9783.
  • 5Lack EE, Cubilla AL, Woodruff JM. Extra-adrenal paragangliomas of the retroperitoneum: A clinicopathologic study of 12 tumors[J]. Am J Surg Pathol, 1980,4(2):109- 120.
  • 6Bennet WM, Hill SF, Ghatei MA, et al. Galanin in the normal pituitary and brain and in pituitary adenomas[J]. J Endocrinol, 1991, 130 (3) :463-467.
  • 7lismaa TP, Shine J. Galanin and galanin receptors[J]. Results Probl Cell Differ, 1999, 26:257-291.
  • 8Berger A, Tueehler C, Ahner D, et al. Elevated expression of galanin receptors in childhood neuroblastic tumors[J]. Neuroendocrinology, 2002, 75 (2): 130-138.
  • 9Piroli GG, Cassataro J, Pietranera L, et al. Progestin regulation of galanin and prolactin gene expression in oestrogen-induced pituitary tumours[J]. J Neuroendocrinol, 2001, 13 (3):302-309.
  • 10Hawes JJ, Narasimhaiah R, Picciotto MR. Galanin and galanin-like peptide modulate neurite outgrowth via protein kinase C-mediated activation of extracellular signal- related kinase[J].Eur J Neurosci,2006,23 ( 11 ):2937-2946.

共引文献1

同被引文献23

  • 1章卫华,叶敏,周荣伟,孙坚.RGD与细胞穿膜肽共修饰脂质体靶向抑制肺癌A549细胞的研究[J].中国生化药物杂志,2014,34(1):46-48. 被引量:5
  • 2颜秋平,李富荣,周汉新.肿瘤特异靶向性药物载体的研究进展[J].国外医学(药学分册),2005,32(3):151-155. 被引量:5
  • 3Xue Ying,He Wen,Wan-Liang Lu,Ju Du,Jia Guo,Wei Tian,Ying Men,Yan Zhang,Ruo-Jing Li,Ting-Yuan Yang,De-Wei Shang,Jin-Ning Lou,Liang-Ren Zhang,Qiang Zhang.Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals[J]. Journal of Controlled Release . 2009 (2)
  • 4Li-Hua Gong,Xiu-Xiu Chen,Huan Wang,Qi-Wei Jiang,Shi-Shi Pan,Jian-Ge Qiu,Xiao-Long Mei,You-Qiu Xue,Wu-Ming Qin,Fei-Yun Zheng,Zhi Shi,Xiao-Jian Yan,Si Jin.??Piperlongumine Induces Apoptosis and Synergizes with Cisplatin or Paclitaxel in Human Ovarian Cancer Cells(J)Oxidative Medicine and Cellular Longevity . 2014
  • 5Yanhua Liu,Jin Sun,He Lian,Wen Cao,Yongjun Wang,Zhonggui He.??Folate and CD44 Receptors Dual-Targeting Hydrophobized Hyaluronic Acid Paclitaxel-Loaded Polymeric Micelles for Overcoming Multidrug Resistance and Improving Tumor Distribution(J)Journal of Pharmaceutical Sciences . 2014 (5)
  • 6Sara E. Zalik.??On the possible role of endogenous lectins in early animal development(J)Anatomy and Embryology . 1991 (6)
  • 7Francis J Giles,Leo I. Gordon,C. Shad Thaxton.Synthetic high-density lipoprotein-like nanoparticles as cancer therapy. . 2015
  • 8Peng Ye,Wendian Zhang, et al.Folate receptor-targeted liposomes enhanced the antitumor potency of imatinib through the combination of active targeting and molecular targeting. International Journal of Nanomedicine . 2014
  • 9Leamon CP.Folate-targeted drug therapy for the treatment of cancer. Curt Opin lnvestig Drugs . 2008
  • 10Quan, G,Pan, X.,Wang, Z.,Wu, Q.,Li, G.,Dian, L.,Chen, B.,Wu, C.Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptortargeted anticancer drug delivery. Journal of nanobiotechnology . 2015

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部